Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
详细信息 查看全文
- 作者：Amy Richardsona ; b ; 1 ; arichardson@chsu.org" class="auth_mail" title="E-mail the corresponding author ; Elizabeth Tolleyc ; Jonathan Hartmanna ; Jasmine Reedusa ; Brandi Bowlina ; Christopher Fincha ; b ; Christopher W. Sandsd ; e ; Timothy Selfa ; b
- 关键词：COPD readmission ; Heart failure ; Readmission ; Beta-blocker ; Guidelines ; Drug therapy
- 刊名：Respiratory Medicine
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：119
- 期：Complete
- 页码：135-140
- 全文大小：311 K
文摘
- •
COPD and HFrEF medications are under-prescribed in patients with both diseases.
- •
We propose that 30 day readmissions should decline if medications for both diseases are prescribed.
- •
ACE inhibitor or ARB plus a beta-blocker were not prescribed at discharge in half of the admissions.
- •
Diabetes may be a comorbidity associated with increased 30 day readmission.